Clinical Trial

Combined Acupressure Effects on Post-Thoracotomy Pain and Lung Volume

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated June 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
Pain is a subjective, sensory and emotionally unpleasant experience resulting from real or hidden injuries in tissues. The pain experience is a subjective and unique experience in physiological and psychological terms and is the first negative sensory experience of the patient after the surgical procedure. Thoracotomy is an invasive surgical incision that causes severe postoperative pain due to the negative effect on the ribs, muscles and peripheral nerves. During thoracic surgery, anatomical lung resection is performed through posterolateral thoracotomy. Surgical incision during thoracotomy surgery is the most severe cause of postoperative pain. Epidural analgesia, peripheral nerve block and systematic treatment methods are used in post-thoracotomy pain management. Opioid use is frequently preferred in post-thoracotomy pain management. Although thoracotomy pain can mostly be controlled with opioid analgesics, excessive use of opioids may lead to respiratory suppression, constipation, suppression of cough, nausea, vomiting and many other possible side effects. Ineffective postoperative pain management may lead to postoperative complications such as increased cardiac workload, prolonged pulmonary rehabilitation and delayed wound healing. The use of holistic non-drug pain relief methods is vital in reducing the need for opioid analgesics and the risk of possible side effects in early postoperative pain management.
Trial Details
NCT Number NCT07411417
Lead Sponsor Özgül Aydemir
Collaborators: Istanbul University - Cerrahpasa, Dogus Universitesi, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Yeditepe University Hospital
Conditions Pain, Acute, Breathing, Mouth, Relaxation; Diaphragm, Cough, Lung Volume
Enrollment 80 participants
Start Date 2025-01-06
Primary Completion 2026-06-06 (estimated)
Study Completion 2027-01-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-13